{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T10:02:40Z","timestamp":1760522560159,"version":"build-2065373602"},"reference-count":13,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T00:00:00Z","timestamp":1578873600000},"content-version":"vor","delay-in-days":4456,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpsmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pain and Symptom Management"],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1016\/j.jpainsymman.2007.01.006","type":"journal-article","created":{"date-parts":[[2007,7,17]],"date-time":"2007-07-17T07:22:42Z","timestamp":1184656962000},"page":"532-538","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Switching from Transdermal Drugs: An Observational \u201cN of 1\u201d Study of Fentanyl and Buprenorphine"],"prefix":"10.1016","volume":"34","author":[{"given":"Sebastiano","family":"Mercadante","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giampiero","family":"Porzio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Fulfaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Aielli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucilla","family":"Verna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corrado","family":"Ficorella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Casuccio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"Riina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Intravaia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"Mangione","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"1986","series-title":"Cancer pain relief","author":"World Health Organization","key":"10.1016\/j.jpainsymman.2007.01.006_bib1"},{"issue":"3","key":"10.1016\/j.jpainsymman.2007.01.006_bib2","first-page":"117","article-title":"Transdermal buprenorphine in cancer pain: a renewed therapeutic opportunity","volume":"2","author":"Mercadante","year":"2006","journal-title":"Support Palliat Cancer Care"},{"key":"10.1016\/j.jpainsymman.2007.01.006_bib3","series-title":"Opioids in\u00a0the treatment of cancer pain","first-page":"81","article-title":"The efficacy in sequential use of buprenorphine and morphine in advanced cancer pain","author":"Atkinson","year":"1990"},{"key":"10.1016\/j.jpainsymman.2007.01.006_bib4","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.ejpain.2005.02.002","article-title":"Interaction of mu-opioid receptor agonists and antagonists with the analgesic effect of buprenorphine in mice","volume":"9","author":"Kogel","year":"2005","journal-title":"Eur J Pain"},{"key":"10.1016\/j.jpainsymman.2007.01.006_bib5","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ejphar.2004.11.052","article-title":"Broad analgesic profile of buprenorphine in rodent models of acute and chronic pain","volume":"507","author":"Christoph","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jpainsymman.2007.01.006_bib6","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jpainsymman.2006.01.013","article-title":"Safety and effectiveness of intravenous morphine for episodic breakthrough pain in patients receiving transdermal buprenorphine","volume":"32","author":"Mercadante","year":"2006","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2007.01.006_bib7","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S0885-3924(97)00082-1","article-title":"TTS-Fentanyl Comparative Trial Group. Transdermal fentanyl versus sustained release oral morphine in cancer pain: preference, efficacy, and quality of life","volume":"13","author":"Ahmedzai","year":"1997","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2007.01.006_bib8","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/0304-3959(95)00180-8","article-title":"Direct conversion from oral morphine to transdermal fentanyl: a multicenter study in patients with cancer pain","volume":"64","author":"Donner","year":"1996","journal-title":"Pain"},{"issue":"4","key":"10.1016\/j.jpainsymman.2007.01.006_bib9","first-page":"441","article-title":"Is there a ceiling effect of transdermal buprenorphine? Preliminary data in cancer patients","volume":"15","author":"Mercadante","year":"2007","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jpainsymman.2007.01.006_bib10","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1213\/01.ANE.0000145066.06538.20","article-title":"Transdermal buprenorphine for treating nociceptive and neuropathic pain: four case studies","volume":"100","author":"Likar","year":"2005","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jpainsymman.2007.01.006_bib11","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0149-2918(03)90019-1","article-title":"Analgesic efficacy and tolerability of transdermal buprenorphine in patients with inadequately controlled chronic pain related to cancer and other disorders: a multicenter, randomized, double-blind, placebo-controlled trial","volume":"25","author":"Sittl","year":"2003","journal-title":"Clin Therap"},{"key":"10.1016\/j.jpainsymman.2007.01.006_bib12","first-page":"882","article-title":"Treatment of cancer-related pain with transdermal buprenorphine: a report of three cases","volume":"12","author":"Schriek","year":"2004","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jpainsymman.2007.01.006_bib13","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.clinthera.2005.02.012","article-title":"Equipotent doses of transdermal fentanyl and transdermal buprenorphine in patients with cancer and non cancer pain: results of a retrospective cohort study","volume":"27","author":"Sittl","year":"2005","journal-title":"Clin Ther"}],"container-title":["Journal of Pain and Symptom Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392407004174?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392407004174?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:59:01Z","timestamp":1760129941000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0885392407004174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":13,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,11]]}},"alternative-id":["S0885392407004174"],"URL":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2007.01.006","relation":{},"ISSN":["0885-3924"],"issn-type":[{"type":"print","value":"0885-3924"}],"subject":[],"published":{"date-parts":[[2007,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Switching from Transdermal Drugs: An Observational \u201cN of 1\u201d Study of Fentanyl and Buprenorphine","name":"articletitle","label":"Article Title"},{"value":"Journal of Pain and Symptom Management","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2007.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 U.S. Cancer Pain Relief Committee. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}